Positive Preclinical Results Unveiled for DPH001

August 23, 2023, Disruptive Pharma Announcement by Peter Åsberg We're delighted to share positive results from our recent preclinical study for DPH001. With our innovative MMC technology, researchers at Disruptive Pharma AB have…

Transformative Materials for Interfacial Drug Delivery

Abstract Drug delivery systems (DDS) are designed to temporally and spatially control drug availability and activity. They assist in improving the balance between on-target therapeutic efficacy and off-target toxic side effects. DDS aid in…